Project Grant R43HL144412

Federal Project Grant Summary Careevolution LLC received $498,576 in federal project grant funding from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) for the period August 15, 2025 through July 31, 2026. The project, titled "Advancing TechQuity: Optimization of the FAITH! App for Dissemination to Promote Cardiovascular Health Among African Americans," involves enhancing a culturally tailored mobile health...

Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded George Washington University a $356,734 Project Grant effective August 1, 2025, through July 31, 2027, under the Cardiovascular Diseases Research program (CFDA 93.837). This R34 feasibility grant supports development and pre-pilot testing of "Support Your Heart," a telephone-based health coaching intervention designed to improve cardiovascular health among young adults. The intervention targets the...

This $150,000 project grant from the National Science Foundation's Computer and Information Science and Engineering program aims to develop technologies to improve cardiac care for patients in rural and tribal areas of Arizona. Clemson University is partnering with Northern Arizona University and community leaders to plan an integrated remote heart monitoring system. The system will utilize deep learning and Markov-based methods to predict deterioration in symptoms for patients with conditions...

The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,314,024 Project Grant under CFDA 93.837 Cardiovascular Diseases Research to Weill Medical College of Cornell University to implement the "Coaching and Navigation by CHWs through Telehealth for High-Risk Hypertension" (CONNECT-HTN) intervention. The project aims to reduce death and hospitalization due to heart disease or stroke by connecting patients with severe hypertension to primary care resources and providing...

Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Ohio State University a $765,931 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) on August 22, 2025, to support a multi-center hybrid effectiveness-implementation trial titled "Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults with Sickle Cell Disease (PF-GUIDE)." The grant funds the development and evaluation of patient-centered, evidence-based...

Grant Award Summary Brown University received an $801.8K Project Grant from the National Heart, Lung, and Blood Institute under the Cardiovascular Diseases Research program (CFDA 93.837) awarded June 15, 2026, with completion expected February 28, 2030. The project will evaluate the Health Zones (HEZ) Initiative—a statewide community intervention model operating across 14 Rhode Island communities—to assess its effectiveness in improving diet quality, physical activity, and cardiovascular disease...

Grant Award Summary Heartpoint Global Inc. received a $1.77M Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025 through August 31, 2027. The funding supports the development and preparation for first-in-human clinical testing of the INTELLISTENT system, a minimally invasive, adjustable pulmonary flow restrictor designed to treat pediatric and congenital heart disease (CHD)...

Grant Award Summary Oregon Health & Science University received a $394,320 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 1, 2025 through July 31, 2028. The award funds a three-year planning project to develop and test the Rural Caregiver Heart Health Education (RICHH) intervention, an evidence-based cardiovascular disease (CVD) risk reduction program adapted for custodial...

Federal Project Grant Award Summary Georgia Tech Research Corporation, in collaboration with Massachusetts General Hospital and Stony Brook University, received a $299,996 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) awarded September 15, 2025, with completion targeted for June 30, 2029. The grant funds the development of data-driven restless multi-armed bandit (RMAB) computational frameworks to optimize...

Percassist Inc. received a $663,129 Project Grant award from the National Heart Lung and Blood Institute of the Department of Health and Human Services. The award was made under the Cardiovascular Diseases Research program (CFDA 93.837), which supports heart and vascular research. The grant funds the development of a percutaneous ventricular assist device for chronic heart failure patients. Specifically, Percassist will design and test a balloon catheter implant that can be delivered minimally...